Skip to Content

210 (Uro-458 hyoscyamine sulfate 0.12 mg / methenamine 81 mg / methylene blue 10.8 mg / phenyl salicylate 32.4 mg / sodium phosphate monobasic 40.8 mg)

Generic Name: hyoscyamine/methenamine/methylene blue/phenyl salicylate/sodium biphosphate

Pill with imprint 210 is Blue, Capsule-shape and has been identified as Uro-458 hyoscyamine sulfate 0.12 mg / methenamine 81 mg / methylene blue 10.8 mg / phenyl salicylate 32.4 mg / sodium phosphate monobasic 40.8 mg. It is supplied by Method Pharmaceuticals, LLC.

Uro-458 is used in the treatment of urinary tract infection and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Uro-458 hyoscyamine sulfate 0.12 mg / methenamine 81 mg / methylene blue 10.8 mg / phenyl salicylate 32.4 mg / sodium phosphate monobasic 40.8 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for 210

Uro-458

Generic Name:
hyoscyamine/methenamine/methylene blue/phenyl salicylate/sodium biphosphate
Imprint:
210
Strength:
hyoscyamine sulfate 0.12 mg / methenamine 81 mg / methylene blue 10.8 mg / phenyl salicylate 32.4 mg / sodium phosphate monobasic 40.8 mg
Color:
Blue
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Urinary antispasmodics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Method Pharmaceuticals, LLC
National Drug Code (NDC):
58657-0458

Get help with Imprint Code FAQs.

More about Uro-458 (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)

Consumer resources

Other brands: Uribel, Urelle, Phosphasal, Uramit MB, ... +13 more

Professional resources

Related treatment guides

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide